《大行報告》麥格理上調安踏(02020.HK)目標價至182元 評級「跑贏大市」
麥格理發表研究報告,重申對安踏(02020.HK)的「跑贏大市」評級,表示對公司提升市場份額有信心,將安踏2021至2022財年盈利預測上調5%,以反映零售需求向好,提高收入及毛利率預期。
該行指,除新疆棉事件帶來短暫正面影響,令消費者減少購買國際品牌、更多關注國產商品外,內地消費高端化亦長遠利好市場發展,將目標價由174元上調至182元,對應2022財年預測市盈率約40倍不變,估計公司旗下Amer品牌今年虧損將持續收窄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.